Evidence map›Paper›PMID 32071266›Full record

ArticlemBio2020

Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.

Minsuk Kim, Emily Vogtmann, David A Ahlquist, Mary E Devens, John B Kisiel, William R Taylor, Bryan A White, Vanessa L Hale, Jaeyun Sung, Nicholas Chia and 2 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 5 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 5 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Colorectal neoplasia-specific amino acid profiles and their diagnostic potential: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Gut microbiota in health and disease.Molecular biomedicine · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Minsuk Kim *Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Emily Vogtmann *Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
David A AhlquistDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Mary E DevensDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
John B KisielDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
William R TaylorDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Bryan A WhiteCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Vanessa L HaleMicrobiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jaeyun SungMicrobiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Nicholas ChiaMicrobiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA Chia.Nicholas@mayo.edu sinhar@mail.nih.gov.
Rashmi SinhaMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Chia.Nicholas@mayo.edu sinhar@mail.nih.gov.
Jun ChenMicrobiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Mayo Clinic · USNational Institutes of Health · USThe Ohio State University · USUniversity of Illinois Urbana-Champaign · US

Funding

Lower Gastrointestinal Cancer StudiesZIACP010198 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SINHA, RASHMI · 2009 to 2025
$6.6M
COLORECTAL CANCER SCREENING--FECAL BLOOD VS DNAU01CA089389 · NCI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI AHLQUIST, DAVID A · 2001 to 2004
$6.5M
Microbial Metabolic Toxicity Drives Colon CancerR01CA179243 · NCI · MAYO CLINIC ROCHESTER · PI CHIA, NICHOLAS · 2014 to 2018
$2.0M
NCI NIH HHS R01 CA179243NCI NIH HHS U01 CA089389
6 · The paper itself

Abstract

Colorectal adenomas are precancerous lesions of colorectal cancer (CRC) that offer a means of viewing the events key to early CRC development. A number of studies have investigated the changes and roles of gut microbiota in adenoma and carcinoma development, highlighting its impact on carcinogenesis. However, there has been less of a focus on the gut metabolome, which mediates interactions between the host and gut microbes. Here, we investigated metabolomic profiles of stool samples from patients with advanced adenoma (

Indexed as

MetabolomeAdenomaAgedBacteriaCarcinogenesisColorectal NeoplasmsFecesFemaleGastrointestinal MicrobiomeHumansMaleMetabolomicsMiddle AgedRNA, Ribosomal, 16SRNA, Ribosomal, 16Scarcinogenesiscolorectal adenomacolorectal cancermetabolomicsmicrobiomemicrobiota

Identifiers

PMID32071266
PMCPMC7029137
OpenAlexW3007647231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.